Page last updated: 2024-08-24

cholesteryl succinate and Benign Neoplasms

cholesteryl succinate has been researched along with Benign Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19905 (55.56)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, M; Fan, Y; Gu, Z; Lin, G; Shi, Y1
Chen, C; Fan, Y; Huang, Y; Lin, G; Zhang, F1
Gao, Y; Ma, HM; Pan, WS; Wang, M; Xu, HT; Yuan, Y; Zhang, XN1
Shinitzky, M1
Dresdale, AR; Sindelar, WF; Skornick, Y1
Nesselhut, T1
Kennedy, PS; McKenna, RJ; Presant, CA; Rao, VS; Smith, JD; Wiseman, CL1
Klausner, JM; Richert, L; Rong, GH; Rozin, RR; Shinitzky, M; Sindelar, WF; Skornick, YG1
Kovarik, J; Munzarová, M; Pacovsky, Z; Rejthar, A; Zemanová, D1

Reviews

1 review(s) available for cholesteryl succinate and Benign Neoplasms

ArticleYear
Membrane fluidity in malignancy. Adversative and recuperative.
    Biochimica et biophysica acta, 1984, Volume: 738, Issue:4

    Topics: Animals; Antigens, Neoplasm; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cholesterol; Cholesterol Esters; Fatty Acids; Homeostasis; Humans; Immunotherapy; Leukemia; Liver Neoplasms; Lymphoma; Membrane Fluidity; Membrane Lipids; Models, Molecular; Neoplasms; Phosphatidylethanolamines; Prognosis; Sphingomyelins; Vaccination; Viscosity

1984

Trials

2 trial(s) available for cholesteryl succinate and Benign Neoplasms

ArticleYear
Clinical responses with active specific intralymphatic immunotherapy for cancer--a phase I-II trial.
    The Western journal of medicine, 1989, Volume: 151, Issue:3

    Topics: Adult; Aged; Cholesterol Esters; Cyclophosphamide; Evaluation Studies as Topic; Female; Humans; Immunotherapy; Injections, Intralymphatic; Male; Middle Aged; Neoplasms; Tumor Cells, Cultured; Vaccines

1989
Active immunotherapy of human solid tumor with autologous cells treated with cholesteryl hemisuccinate. A Phase I study.
    Cancer, 1986, Aug-01, Volume: 58, Issue:3

    Topics: Cholesterol Esters; Clinical Trials as Topic; Dose-Response Relationship, Immunologic; Humans; Hypersensitivity, Delayed; Immunotherapy; Neoplasm Metastasis; Neoplasms; Skin Tests; Time Factors

1986

Other Studies

6 other study(ies) available for cholesteryl succinate and Benign Neoplasms

ArticleYear
NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel.
    Colloids and surfaces. B, Biointerfaces, 2017, Dec-01, Volume: 160

    Topics: Animals; Cell Line, Tumor; Cholesterol Esters; Delayed-Action Preparations; Docetaxel; Drug Delivery Systems; Drug Liberation; Humans; Hydrogen-Ion Concentration; Liposomes; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Oligopeptides; Polyethylene Glycols; Taxoids; Xenograft Model Antitumor Assays

2017
Study of the pH-sensitive mechanism of tumor-targeting liposomes.
    Colloids and surfaces. B, Biointerfaces, 2017, Mar-01, Volume: 151

    Topics: Calorimetry, Differential Scanning; Cholesterol Esters; Drug Delivery Systems; Electric Conductivity; Hot Temperature; Humans; Hydrogen-Ion Concentration; Linoleic Acid; Liposomes; Microscopy, Electron, Transmission; Nanotechnology; Neoplasms; Oleic Acid; Phosphatidylethanolamines; Surface Properties; Temperature; Tumor Microenvironment

2017
Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo.
    Drug development and industrial pharmacy, 2012, Volume: 38, Issue:9

    Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Chemistry, Pharmaceutical; Cholesterol Esters; Drug Delivery Systems; Excipients; Fluorouracil; Humans; Hydrogen-Ion Concentration; Liposomes; Mice; Mice, Inbred Strains; Molecular Conformation; Neoplasms; Particle Size; Random Allocation; Solubility; Surface Properties; Surface-Active Agents; Tissue Distribution; Xenograft Model Antitumor Assays

2012
Induction of delayed hypersensitivity reactions in cancer patients by cholesterol-hemisuccinate-treated autologous tumor cells.
    Journal of the National Cancer Institute, 1983, Volume: 70, Issue:3

    Topics: Carcinoma; Cell Separation; Cholesterol Esters; Humans; Hypersensitivity, Delayed; Immunity, Cellular; Immunologic Techniques; Immunotherapy; Melanoma; Membrane Lipids; Neoplasms; Sarcoma; Skin Tests

1983
Influence on antigen exposition of tumor cells by membrane active substances and viral infections.
    Hybridoma, 1993, Volume: 12, Issue:5

    Topics: Antigens, Neoplasm; Breast Neoplasms; Cell Membrane; Cholesterol Esters; Female; Humans; Immunoglobulin G; Neoplasms; Newcastle disease virus; Tumor Cells, Cultured; Vaccination; Vaccines; Vitamin A; Vitamin E

1993
Skin tests with autologous cholesteryl hemisuccinate treated tumour cells in cancer patients.
    Cancer immunology, immunotherapy : CII, 1985, Volume: 20, Issue:2

    Topics: Breast Neoplasms; Cholesterol Esters; Female; Humans; Hypersensitivity, Delayed; Melanoma; Neoplasms; Ovarian Neoplasms; Skin Tests

1985